The Big Picture: Dr. Puja Uppal, Family Medicine, “The news about GLP-1 RA medicines keeps getting better by the day.”
Doctor’s Expert Insights About GLP-1 RAs for Colorectal Cancer in Georgia
Know this: “Wow, this is another blockbuster finding to add to the positive effects of GLP-1 medications. Researchers from Case Western Reserve University are revealing a potential breakthrough–a diabetes drug may significantly lower colorectal cancer risk. The study underscores the importance of exploring existing medications for new therapeutic purposes. It’s a promising step forward in the fight against one of the more dangerous forms of cancer. GLP-1 RA are medicines like Ozempic, Semaglutide, Trulicity, and others. Also, make sure you’re talking to your healthcare team and know your A1c blood values ” Dr. Adriana Davis, Family Medicine.
Beyond the news: This discovery could pave the way for more effective prevention strategies to potentially reduce the overall incidence and mortality rates of colorectal cancer.
Hinesville Focus: Watch a Short Video about the New Diabetes Medicine–Mounjaro (Tirzepatide).
Health Alert for Hinesville
Key Drivers in Liberty County:
The study found that patients who took GLP-1 RAs had a 44% reduction in the risk of colorectal cancer compared to those who took insulin, and a 25% reduction compared to those who took metformin.
The research involved analyzing over 1.2 million patient records and comparing colorectal cancer incidence among those treated with different anti-diabetic medications.
Keep in mind, that this is preliminary. More research is needed, including clinical trials. The good news here is that these results suggest that GLP-1 RAs may be a promising way to prevent colorectal cancer in patients with diabetes.
“The research is critically important for reducing incidence of CRC in patients with…
Read the full article here